Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as combined with CBT-intervention in the treatment of pathological gambling (PG). The study period is 2011-2014 during which one hundred Pathological Gamblers will be recruited to participate to this placebo-controlled double-blind trial.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Finnish Institute for Health and Welfare; National Institute for Health and Welfare, Finland
• Treatments: Naltrexone

Criteria

Inclusion Criteria:

• pathological gambling (scores 5+ from SOGS-R and DSM-IV criteria)

Exclusion Criteria:

• acute hepatitis

• severe liver or kidney dysfunction

• suicide risk or severe depression or other untreated mental health problem

• participation to other gambling research at the same time

• the use of drugs (especially opiates)

• pregnancy

• prisoners

• retarded and mentally ill patients were also excluded